EPICENTRE recently added a new ribosomal RNA removal kit to its lineup. The Ribo-Zero™ rRNA Removal Kit (Gram-Negative Bacteria) removes >99% of the 23S and 16S, and >97% of the 5S rRNA from both intact and partially degraded RNA from Gram-negative species. A kit for Gram-positive species is in the works and should be available soon.
Unconfigured Ad
Collapse
X
-
Not with this kit, so far. Theoretically, you could use oligo (dT) to get rid of eukaryotic mRNA, and then remove ribosomal RNA with two passes (eukaryotic and bacterial). However, you'd be dealing with very small amounts of bacterial RNA.
A better solution may be Ambion's MicrobEnrich kit, followed by the RiboZero kit. With either approach, you could prepare Illumina-compatible libraries for sequencing.
Comment
-
What sorts of yields do you get from E. coli RNA?
We have been trying to use Invitrogen ribominus but our yields are abysmal. We start with 10 ug of RNA and usually end up with less than 100 ng (by fluorimetry) after a single pass. (For the SOLiD, two passes and 200-500 ng of ribo-minus RNA are recommended.)
--
Phillip
Comment
-
The Ribo-Zero kits use a completely different method from the mRNA-Only kits for rRNA removal. They are more efficient in terms of rRNA removal. The yield will depend on your sample type and purity.
We do have an evaluation program in the U.S.; for other countries, you would need to contact your local distributor.
Comment
-
Thank you for an answer. I can not find how that kit works.
Is that method similar to the microbexpress? I used microbexpress and it did not work for me (the results were worse than with mRNA only)
I work with Gluconacetobacter (Acetobacteriaceae). Do you have any information for usage this kit in bacteria different than E.coli?
Is ribozero enzymatic or hybridization method?
Martha
Comment
-
The Ribo-Zero kits do not use enzymatic digestion, but are based on a proprietary hybridization technology for rRNA removal. The Gram-negative kit will work with a broad range of species, including Gluconacetobacter. I'm not sure why the MicrobExpress kit didn't work for you; it might be a good idea to troubleshoot that with Ambion tech support before trying a different method.
Comment
-
The 5th post in the thread answers your question for E. coli.
I don't work for Epicentre, but Ribo-zero looks like it is in the same "family" of ribo-depletion methods as Invitrogen's Ribo-minus. If so, it would work by hybridization to ribosomal RNAs by oligos attached to magnetic beads. Subsequent removal of the beads then also removes the ribosomal RNA. Okay, that leaves out a step, but the basic idea is there.
We typically got very poor yields when using ribo-minus. I have no idea why. Maybe something in our RNA preps in concert with something in the kit was degrading the non-bound RNA? Or we were getting non-specific binding?
Anyway, ribo-depletion methods that rely on oligo hybridization will be less capable of removing rRNA that is degraded to the extent that coverage of the oligos on the rRNA is less than 100%. The fewer oligos that bind to your species's rRNA, the more critical that the rRNA be perfectly intact to allow its removal.
--
Phillip
Comment
Latest Articles
Collapse
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
Yesterday, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 02:55 AM
|
0 responses
13 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 02:55 AM
|
||
|
Started by SEQadmin2, 07-24-2026, 12:17 PM
|
0 responses
13 views
0 reactions
|
Last Post
by SEQadmin2
07-24-2026, 12:17 PM
|
||
|
Started by SEQadmin2, 07-23-2026, 11:41 AM
|
0 responses
13 views
0 reactions
|
Last Post
by SEQadmin2
07-23-2026, 11:41 AM
|
||
|
Started by SEQadmin2, 07-20-2026, 11:10 AM
|
0 responses
24 views
0 reactions
|
Last Post
by SEQadmin2
07-20-2026, 11:10 AM
|
Comment